Estrogen Blockers Market, By Product Type (Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors, Estrogen Receptor Downregulators (ERDs), Others), By End User (Hospitals and Clinics, Research Institutes, Individuals), By Application (Breast Cancer Treatment, Hormone Replacement Therapy (HRT), Infertility Treatment, Post-Menopausal Osteoporosis, Others), By Distribution Channel (Hospitals and Specialty Clinics, Retail Pharmacies, Online Stores, Others), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Estrogen blockers are medicines that are used by FTM (Female to Male) individuals as part of their hormone replacement therapy (HRT) to suppress the effects of estrogen in the body. They can also help to promote the development of male secondary sexual characteristics. There are many different types of Estrogen Blockers available, and some are more effective than others.
Estrogen blockers can be taken in the form of tablets or injections. They are usually prescribed as part of a larger HRT treatment plan and are generally well tolerated by individuals who take them. For the most part, a hospital stay is not required when taking these medications, and they can often be given at home.
Market Dynamics
Estrogen blockers are largely used to treat hormone-related diseases like polycystic ovary syndrome (PCOS), endometriosis, and breast cancer. The demand for estrogen blockers rises as the prevalence of these illnesses rises internationally, fueling market expansion.
Like any drug, estrogen blockers have potential risks and adverse effects. Hot flashes, mood swings, joint discomfort, and increases in cholesterol levels are examples of typical side effects. In some circumstances, long-term usage of estrogen blockers may raise the risk of cardiovascular issues and bone loss. Patients' compliance with and acceptance of estrogen blockers may be impacted by safety worries and possible side effects.
Key features of the study:
This report provides in-depth analysis of the global estrogen blockers market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global estrogen blockers market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Novartis AG, AstraZeneca PLC, Eli Lilly and Company, Merck & Co., Inc., Bristol Myers Squibb Company, Johnson & Johnson, Sanofi S.A., AbbVie Inc., GlaxoSmithKline plc
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global estrogen blockers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global estrogen blockers market
Detailed Segmentation:
Global Estrogen Blockers Market, By Product Type:
Selective Estrogen Receptor Modulators (SERMs)
Aromatase Inhibitors
Estrogen Receptor Downregulators (ERDs)
Others
Global Estrogen Blockers Market, By Application:
Breast Cancer Treatment
Hormone Replacement Therapy (HRT)
Infertility Treatment
Post-Menopausal Osteoporosis
Others
Global Estrogen Blockers Market, By Distribution Channel:
Hospitals and Specialty Clinics
Retail Pharmacies
Online Stores
Others
Global Estrogen Blockers Market, By End User:
Hospitals and Clinics
Research Institutes
Individuals
Global Estrogen Blockers Market, By Region:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Company Profiles:
Pfizer Inc.
Novartis AG
AstraZeneca PLC
Eli Lilly and Company
Merck & Co., Inc.
Bristol Myers Squibb Company
Johnson & Johnson
Sanofi S.A.
AbbVie Inc.
GlaxoSmithKline plc
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Application
Market Snapshot, By Distribution Channel
Market Snapshot, By End User
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Increasing Prevalence of Hormone-related Disorders
Restraints
Side Effects and Safety Concerns
Opportunities
Expansion of Indications
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Estrogen Blockers Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Estrogen Blockers Market , By Product Type, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Selective Estrogen Receptor Modulators (SERMs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Aromatase Inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Estrogen Receptor Downregulators (ERDs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Global Estrogen Blockers Market , By Application, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Breast Cancer Treatment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Hormone Replacement Therapy (HRT)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Infertility Treatment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Post-Menopausal Osteoporosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
7. Global Estrogen Blockers Market , By Distribution Channel, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Hospitals and Specialty Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Online Stores
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
8. Global Estrogen Blockers Market , By End User, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Hospitals and Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Individuals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
9. Global Estrogen Blockers Market , By Region, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, By Country, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Country 2018 –2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
Middle East & Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
10. Competitive Landscape
Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
AstraZeneca PLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Eli Lilly and Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Merck & Co., Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Bristol Myers Squibb Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Johnson & Johnson
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Sanofi S.A.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
AbbVie Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
GlaxoSmithKline plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
11. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on "Estrogen Blockers Market” - Global forecast to 2030